Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

January Salas-McKee

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Human Vaccines & Immunotherapeutics|February 9, 2019
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapyJanuary Salas-Mckee, Weimin Kong, Whitney L Gladney, et al.
Genome Biology|January 19, 2019
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificityChristopher L Nobles, Shantan Reddy, January Salas-McKee, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Immunity|September 30, 2023
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, M Angela Aznar, Andrew J Rech, et al.
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|February 9, 2019
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapyJanuary Salas-Mckee, Weimin Kong, Whitney L Gladney, et al.
Genome Biology|January 19, 2019
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificityChristopher L Nobles, Shantan Reddy, January Salas-McKee, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Immunity|September 30, 2023
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, M Angela Aznar, Andrew J Rech, et al.
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Pageof 1